GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Debt-to-Revenue

ACME Laboratories (DHA:ACMELAB) Debt-to-Revenue : 0.72 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

ACME Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was BDT16,639 Mil. ACME Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was BDT6,261 Mil. ACME Laboratories's annualized Revenue for the quarter that ended in Mar. 2024 was BDT32,018 Mil. ACME Laboratories's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.72.


ACME Laboratories Debt-to-Revenue Historical Data

The historical data trend for ACME Laboratories's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Debt-to-Revenue Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Revenue
Get a 7-Day Free Trial 0.86 0.84 0.74 0.67 0.77

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.74 0.72 0.69 0.72

Competitive Comparison of ACME Laboratories's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's Debt-to-Revenue falls into.



ACME Laboratories Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

ACME Laboratories's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(14599.132 + 6230.276) / 26947.708
=0.77

ACME Laboratories's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(16639.291 + 6261.459) / 32017.92
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


ACME Laboratories Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ACME Laboratories (DHA:ACMELAB) Business Description

Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines